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ABSTRACT  
Unani System of Medicine (USM) is being practised as traditional, alternative and complementary medicine in India and other countries. In this 
system of medicine, medicinal plants are extensively used in the treatment of various kind of diseases since time immemorial.  Herbo-mineral 
origin drugs are the main components of Unani Pharmacopoeia. Jamun (Syzygium cumini Linn) is one of the medicinal plants used for 
therapeutic purposes in Dhayābīṭus Ḥārr (diabetes mellitus),  Ishāl-e- Damwī (haemorrhagic diarrhoea), Is’haal-i-Safrāwī (bilious diarrhoea), 
Ḍu‘f al-Ishtihā’(loss of appetite), Zaḥīr (dysentery) and Qulā (oral ulcer). In recent past its fruits, seeds, leaves, stem bark and its secondary 
metabolites have shown medicinal properties in various experimental and clinical studies. In this review we have tried to explore its ethno-
botanical uses and pharmacological actions described in classical literature and scientific publications based on experimental studies. It is 
found that this plant plays an important role in prevention and management of non-communicable diseases such as Dhayābīṭus Ḥārr (diabetes 
mellitus), Sarṭān (cancer), Niqris (gout), ischaemic heart disease etc. Several preclinical studies have revealed that it has Muḥallil-i- Awrām 
(anti-inflammatory), Muḥāfiẓ-i- Qalb (cardio protective), Dafi‘-i-Ḥummā (anti-pyretic) and Muqawwī-i-Jigar (hepatotonic) properties. It also 
possesses anti-diabetic potential activity and considered as a potent anti-diabetic plant. 
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Unani System of Medicine (USM) is being practised as 
traditional, alternative and complementary medicine in India 
and other neighbouring countries. Unani pharmacopoeia is 
enriched with herbo-mineral single drugs and their 
formulations. Jamun (Syzygium cumini Linn, Syn. Eugenia 
jambolana Lam.), is one of the important medicinal plants 
having potential to treat several ailments successfully. It is 
found that this plant plays an important role in prevention 
and management of non-communicable diseases such as 
Dhayābīṭus Ḥārr (diabetes mellitus), Sarṭān (cancer), Niqris 
(gout), ischaemic heart disease (IHD) etc. In Unani System of 
Medicine, this plant is described as Qābiḍ (astringent), Kāsir-
i-Riyāḥ (carminative), Mudirr-i-Bawl (diuretic), Dāfi‘-i-
Dhayābīṭus (antidiabetics), Sayalan al-Raḥim (leucorrhoea), 
Dafi‘-i-Ḥummā (antipyretics) and Qurūḥ (wounds).(3)  
This plant is a large evergreen tropical glabrous tree and 
consists of about 90 genera and 2,800 species. (1) Its 
existence is described by Ibn Batuta who visited India in 
1332, A.D. as one of the fruits of Delhi. (2)  It is found 
throughout in India and other countries like Nepal, 
Myanmar, Sri Lanka, Indonesia, Pakistan, Bangladesh, 
Malaysia, Thailand, Philippines, Australia and other tropical 
regions of the world including South America and 
Madagascar since ancient time.(3)  
Its different parts have been indicated in different ailments 
and its therapeutic application varies according to system of 
medicine. In Unani medicine, its seed kernel, commonly 
known as Khasta Jamun, is used for the management of 
diabetes mellitus. There are many compound formulations in 
which Jamun is added as one of the constituents of the 
formulation. Safoof -i- Khasta, Safoof-i- Ziyābetus and Qurs-i-
Ziābetus are some important compound formulations 
indicated for diabetes mellitus. It may emerge as a potent 
antidiabetic plant. 
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Scientific Classification (4, 5):  
Its taxonomy is tabulated in table- 1.         









Vernaculars names: It is a very popular plant medicine but 
it is known by various names in different vernaculars such 
as: 
Urdu: Jaman, (6, 7) Phalenda (6) 
Hindi: Jam,(3,6,8)Jamun, (6,9,10,11) Jaman,(3,6,7,8, 10) Phalanda,(6) 
Phalinda(6,8) 
English:  Black plum, (6, 8, 10, 12) Black Berry (8) 
Sanskrit:  Jambula, (6, 8) Jambu (6, 8, 9, 12, 13) 
Telugu:  Neereedu, (3) Neredu, (6, 11) Jambuvu, (6, 9) Naeraedu, 
(8)Nesedu(10) 
Morphological characteristics:  
It is a large evergreen glabrous tree up to 30 meters height 
and girth of 3.6 meters. It is also considered as fast growing 
tree, reaching full size in 40 years. It ranges up to 100 ft. (30 
m) in India and it may attain a spread of 36 ft. (11 m) and a 
trunk diameter of 2 or 3 ft. (0.6-0.9 m).(14)   
Bark: It is pale brown, slightly rough on old stems with 
shallow cracks. (6) The bark on the lower portion of the stem 
is rough, cracked, flaking, and discoloured while it is light 
gray to gray or grayish-brown and smooth toward the upper 
portion. (15)  
Leaves: They are variable, usually 7.5-15 by 3.8- 6.3 cm. 
lanceolate, elliptic-oblong or broadly ovate- elliptic, acute, 
acuminate or sub obtuse,  coriaceous, smooth and shining 
above, with numerous close parallel fine secondary nerves 
uniting to form an intramarginal vein.(6)  
Flowers: The flowers do not exhibit much variation except in 
colour. They may be white to creamy white or occasionally 
slightly green. The flowers are borne in clusters of a few to 
40 in number on terminal or axillary panicled racemes. (16) 
Flowers are 7.5-13mm. across, whitish, fragrant, sessile 
arranged mostly in threes in tricotomous panicles 3.8-10 cm. 
long which usually appear from the scars of fallen leaves. (6) 
The flowering starts in March and continues until May. Full 
blooming occurs in April to May. (16) 
Fruit: Its fruit is a berry, which initially appears green, and 
gradually turn to light violet-red or purplish-red, and finally 
dark purple to black at full maturity. In most of the habitats, 
the fruiting starts in May and bunches of young fruits appear 
after 15–25 days from fruit initiation. Unripe mature fruits 
appear about 30–40 days after flowering. (16)  
Parts Used:  Unani classical literature describes its different 
parts having medicinal values. It has been used in multiple 
dosage forms for various therapeutic purposes. Its different 
parts such as Leaves (7,8,13,19,20), Stem bark (7,8 13, 17,19,20,21), 
Fruit (7,8,13,18,19,20), Seeds kernel (7,8,17, 18,19,20,21) Flower (19,20) 
and roots (7) are being used in traditional medicine for the 
treatment of various ailments.  
Temperament: Some Unani physicians described its 
temperament as Bārid2 Yābis1or 2 (Cold and Dry) (13, 20, 22) or 
Bārid3 Yābis2 (Cold and Dry) (13) and some mentioned its 
temperament as Bārid 2 Yābis3 (Cold and Dry) (23, 24) but 
Hakim Najmul Gani described the temperament of this plant 
as Bārid2 Raṭb1 (Cold and Moist) and that of seed is Bārid2 
Yābis2 (Cold and Dry). (24) 
Dosage: In classical literature, the dosage of its seed kernels 
is 1-3(18, 22) or 2 gms (21) per day orally. But Unani 
Pharmacopoeia of India describes the oral dose of seed 
kernel as 3-5 gms per day (17) but dosage of the leaves is 5-10 
gms per day. 
Adverse effects: As reported in classical literature, this drug 
sometimes causes flatulence, delayed digestion (18, 21, 23), 
inflammed larynx and lungs (22, 23) and emphysema as side 
effect. (13) Common salt and Filfil Siyah (Piper nigram) may be 
used as correctives to minimize the side effects. (18, 21, 23, 24) 
Ethno-botanical therapeutic Uses: 
Stem bark: Its bark has medicinal value and is used as 
digestive, Qābiḍ (astringent) (8, 9) and anthelmintic to the 
bowels. (6) It is indicated in classical literature for Iltihāb al-
Shu‘ab (bronchitis), Rabw (bronchial asthma), Zaḥīr 
(dysentery), Najis-i-Dam (blood impurities) and Qurūḥ 
(ulcers). (6)  
Seed: The seeds are known as good Qābiḍ (astringent) to the 
bowels, (6) Muḥallil-i- Awrām (anti-inflammatory), anti-
arthritic, Dafi‘-i-Ḥummā (antipyretic) and Musakkin-i-Alam 
(analgesic). (11)It is indicated as Dafi‘-i-Dhayābīṭus 
(antidiabetic agents) in Dhayābīṭus Ḥārr (diabetes mellitus). 
(6) It diminishes the quantity of sugar in urine and allays the 
unquenchable thirst of diabetes. (8) The seed is also used in 
Ḍu‘f al-Mi‘da (weakness of stomach), Ḍu‘f al-Jigar (weakness 
of liver), Musakkin-i-Sozish and Ishāl-i-Damwī wa Ṣafrāwī 
(haemorrhagic and bilious diarrhoea). (17)  
Leaves: Its leaves are also used as Qābiḍ (astringents) in 
Zaḥīr (dysentery) (6) and Muḥallil-i- Awrām (anti-
inflammatory) in Qulā‘(stomatitis). It has been used in the 
treatment of vomiting and haemorrhoids. It is also used as 
anti-venom. (13)   The ash of leaves is used for strengthening 
the teeth and the gums. (6) Decoction of an equal amount of 
its stem bark and leaves subsides the smell of armpit. They 
are used as a paste to subside the burning sensation of the 
body in case of burn. (13)   
Fruits:  The fruits are considered as a general tonic. They are 
used as tonic to the liver and enrich the blood. They 
strengthen Asnān-o-Litha (teeth and gums) and act as Qābiḍ 
(astringent) in Is’hāl-i- Ṣafrāwī (bilious diarrhoea). They are 
also used in sore throat and ringworm in the head. (6) The 
vinegar made of the fruit is tonic, Muqawwī-i-Mi‘da 
(stomachic), Qābiḍ (astringents) and kāsir-i-Riyāḥ 
(carminative). (6, 8) It is useful in diseases of the spleen. (8) It is 
also used as a Mudirr-i-Bawl (diuretic) and Dafi‘-i-Dhayābīṭus 
(antidiabetic). (6, 8) The fruits are a good source of iron, used 
as an effective medicine against heart diseases, liver diseases 
and asthma. (11)  
Therapeutic Uses:  
In Unani literature this plant has been indicated for various 
ailments in different dosage form. Those indications are 
summarised below. 
1. Zaḥīr (Dysentery)(2,12,13,18,24,26) 
2. Ishāl-e- Damwī (Haemorrhagic diarrhoea) 
(9,12,13,17,18,21,23,24) 
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3. Is’hāl-i- Ṣafrāwī (Bilious diarrhoea)(2,9,12,13,17,18,21,24,26) 
4. Ḍu‘f al-Mi‘da ( Weakness of stomach) (2,18,21,23) 
5. Warm-e- Ṭiḥāl (Splenitis) (18,23) 
6. Dhayābīṭus Ḥārr (Diabetes mellitus)(9,11,12,18,21,25,26) 
7. Qulā‘ (Oral ulcer / Stomatitis) (13,24,26) 
8. Ḥummā (Fever)(6,8,13,24) 
9. Bawl Zulālī (Albuminuria) (25) 
10. Tasaddud Shaḥmī Kilsī (Atherosclerosis)(25) 
11. Bacteriuria(25) 
12. Hasāt-i-Mathāna (Bladder Stone)(25) 
13. Sarṭān (Cancer) (25) 
14. Cholecystosis(13,24,25) 
15. Waram -al-Mathāna (Cystitis)(25) 
16. Usr al-Bawl (Dysuria)(25) 
17. Ūdhīmā (Oedema) (25) 
18. Gallstone(25) 
19. Niqris (Gout)(25) 
20. Bawl al-Dam (Haematuria)(25)  
21. Waram (Inflammation)(12,13,25) 
22. Hasāt-i- Kulya (Kidney Stone)(25) 
23. Low Blood Pressure (25) 
24. Waram al-Kulya (Nephritis)(25) 
25. Ḥudār (Rheumatism)(25) 
26. Sujan (Swelling)(25) 
27. Bandīsh-i- Idrār (Water/Urine Retention)(25)  
28. Uqr (Infertility)(11) 
29. Ḍu‘f al-Ishtihā’(Loss of appetite)(13,18,21,24) 
30. Ḥassāsiyat (Allergy)(18) 
31. Qāṭi‘-i-Bāh (Anaphrodisiac) (13,23,24) 
32. Ḍu‘f al litha(Weakness of gums)(17)  
33. Dā’al-Tha‘lab (Alopecia Areata)(6,13,24) 
34. Sore throat(6,13,24) 
35. Iltihāb al-Shu‘ab (Bronchitis) (6,13,24) 
36. Rabw (Bronchial Asthma) (6,13,24) 
37. Najis-i-Dam (Blood Impurities)(13,24) 
38. ‘Uṭāsh Mufriṭ (Polydipsia)(13,24) 
39. Riyāḥ (Flatulence)(13,24) 
Pharmacological Actions:  
This plant has been described in various classical literature 
of Unani medicine as a single drug and its actions has been 
described as follows.   
1. Dafi‘-i-Ḥummā (Antipyretic)(13,18,21,24)  
2. Qābiḍ (Astringent)(2,6,8,9,13,18,21,22,24,25)  
3. Kāsir-i-Riyāḥ (Carminative)(2,6,8,12,13,24,25)  
4. Mushtahī (Appetizer)(13,18,21,24) 
5. Muḥallil-i- Awrām (Anti-inflammatory)(25)  
6. Qaat-i-Ṣafrā (Anti-bilious)(6,9,13,22,24) 
7. Dafi‘-i-Dhayābīṭus (Antidiabetic) (2,6,8,9,11,12,13,14,24,25,26)  
8. Muqawwī-i-Jigar (Hepatotonic)(11,13,18,21,23,24)  
9. Dafi‘-i-Jarāsīm (Antibacterial)(11,12,25) 
10. Dafi‘-i-Fīṭar (Anti-fungal activity)(2,11,25) 
11. Muḥāfiẓ-i- Qalb (Cardio-protective effects)(18) 
12. Dafi‘-i-Is’hāl (Anti-diarrheal effects)(12,17,26) 
13. Dafi‘-i-Ḥassāsiyat (Anti-allergic effects)(22) 
14. Musakkin-i-Alam (Analgesic)(25) 
15. Tiryāq (Antidote) for nux-vomica(25) 
16. Dafi‘-i-Tahabbujī (Antiedemic)(25) 
17. Dafi‘-i-‘Ufunat (Antiseptic)(25) 
18. Dafi‘-i-Tashannuj (Antispasmodic)(25) 
19. Quwwat-i-Bāh (Aphrodisiac)(23,25) 
20. Muqawwī-i-Mi‘da (Stomachic) (2,8,9,12,13,17,18,21,22,23,24) 
21. Mudirr-i-Bawl (Diuretic)(2,6,8,9,12,25) 
22. Uqr (Sterility)(11) 
23. Muṣaffī-i-Dam (Blood Purifier)(13,22,24) 
24. Muqawwiyāt-i-Asnān-o-Litha (Strengthen the gums and 
teeth)(13,24)  
25. Khafaqān (Palpitation)(13,24)  
 
Chemical constituents:  
Phytochemical studies have conducted and various chemical 
constituents have been isolated from different parts of the 
plant. 
Seed:  It contains tannin (19%),(3,12) ellagic acid,(3,12) gallic 
acid (1-2%),(3,12)  glycoside (jamboiine), starch and small 
quantity (0.05%) of a pale-yellow essential oils(3,12), 
chlorophyll, fat, resin, albumin,(8) hexahydroxydiphenoyl 
glucose and its isomer  hexahydroxydiphenic acid, 1- 
galloylglucose(27) and elements such as zinc, chromium, 
vanadium, potassium and sodium.(14) 
Fruit: It contains anthocyanins, citric, malic and gallic acids, 
glucose and fructose (12), and oxalic acid. (3) It is reported that 
the colour of the fruits might be due to the presence of 
anthocyanins namely delphinidin-3-gentiobioside and 
malvidin-3- laminaribioside along with petunidin-3-
gentiobiosid. (14)  
Leave: Aliphatic alcohols, sitosterol, betulinic acid, crategolic 
acid (12), Quercetin (0.0085%), myricetin (0.023%), 
myricitrin (0.009) and myricetin 3-O-4”-acetyl. - α -L-
rhamnopyranoside (0.059%) are found in it. (28) 
Flower: It contains triterpenic acids- oleanolic acid (3) 
crategolic acid. (12)Three triterpenoids are reported to be 
present in the flower. One of these is acetyl oleanolic acid, 
the other two designated eugenia-triterpenoid A, and 
Eugenia triterpenoid B have not been identified. The flowers 
also contain flavonoids isoquercitrin, quercitin, kaempferol 
and myricetin, ellagic acid. (3) 
 Stem bark: It contains beta-sitosterol, gallic acid, friedelin, 
betulinic acid, tannins (12%), ellagic acid and myricetin. (3) 
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Pharmacological activities:  
1. Hypoglycaemic activity:  In a study conducted by 
Madhuri Pandey and Aqueel khan it revealed that feeding of 
diets containing 15% unextracted (intact), 15% defatted S. 
cumini seeds and 6% watersoluble gummy fibre for 21 days 
significantly lowered (26-28%) the blood glucose level and 
significantly improved glucose tolerance in both normal and 
diabetic rats when compared with their respective control. 
This study suggest that S. cumini seed diets has 
hypoglycaemic activity. (29) 
2. Anti-inflammatory activity: Muruganandan et al in their 
experimental study showed that 70% ethanolic extract of S. 
cumini bark had significant anti-inflammatory activity 
comparable to that of acetylsalicylic acid (300 mg/kg/oral). 
(30) It proves that it has as a good anti-inflammatory 
property. 
3. Cardio-protective activity: The hydro-alcoholic extract 
from the fruits of S. cumini was evaluated for its 
antihypertensive and vasorelaxant effect in the study 
conducted by Herculano et al. Its results suggested that 
extract induced hypotension and caused antihypertensive 
effects. (31) This result justifies the application of the fruits of 
this plant as cardioprotective drug.   
4. Antiretinitis: Priya et al. (2013) studied the binding 
affinity of five anthocyanin compounds from S. cumini fruit 
peel with the X-linked retinitis pigmentosa (RP2) gene (a 
mutant of this gene causes loss of vision in humans) and 
revealed cyanidin 3, 5 diglucoside with lowest G score (–
12.62 kcal/mol) as an inhibitor that could be of potential use 
in the treatment of retinitis pigmentosa in humans. (32) 
5. Antipyretic activity: In an experimental study Mahaptra 
et al reported that seed extract of S. cuminii had anti-
inflammatory and anti-pyretic activity evaluated in adult 
male Charles-Foster rats (120-160 g). The seed extract (50, 
100 and 200 mg/kg, i.p.) produced significant antipyretic 
activity against yeast induced pyrexia in rats. (33, 34) 
6. Anti-Diarrhoeal Activity: It has been used for controlling 
diarrhoea since a long time. A study   reported that bark 
extract of Eugenia jambolana Lam. had significant inhibitory 
activity against Castor oil-induced diarrhoea in experimental 
animal models. (35) 
7. Hepatoprotective activity: It possesses hepatoprotective 
property as reported in the literature. Das and Sarma in their 
study reported that the Ethanolic Extract of The Pulp of 
Eugenia Jambolana Lam. at doses of 100mg/kg and 
200mg/kg possess significant Hepatoprotective activity in 
rats induced with hepatotoxic paracetamol. (36)  In another 
study it was revealed that the methanolic extract of Eugenia 
jambolana Lam. at an oral dose 400mg/kg/day, was effective 
against the hepatotoxicity which was caused by carbon 
tetrachloride (CCL4).(37)  
8. Anti-Cancer Activity: For Sarṭān (cancer) treatment, nine 
plant-derived compounds have been approved for clinical 
use in the United States. They include vinblastine, vincristine 
and paclitaxel. There are few reports that have revealed the 
potential role of Syzygium cumini (L.) fruits to combat cancer. 
(19) 
Anthocyanin-rich Java plum fruit extract (JPE) clearly 
demonstrated the anti-cancer properties not only against the 
early stage HCT-116 human colon cancer cells but also 
induced apoptosis and inhibited self-renewal ability in colon 
cancer stem cells (CSCs).(38) Mittal et al developed and 
characterized silver nanoparticles (AgNPs) of Syzygium 
cumini (L.) fruit extract in vitro. The size of newly 
synthesized silver nanoparticles and their size were 
observed to be 10-15 nm. Important findings of this study 
were the recognition of biomolecules accountable for the 
synthesis of silver nanoparticles and the mechanism of 
biosynthesis. Presence of flavonoids in Syzygium cumini (L.) 
was mainly responsible for the reduction and stabilization of 
nanoparticles. The nanoparticles were observed to devastate 
Dalton lymphoma cell lines in vitro. Silver nanoparticles 
(100μg/mL) were found capable to reduce Dalton lymphoma 
(DL) cell lines viability up to 50 %.( 39) 
9. Anti-Leishmania activity: In a study, Rodrigues et.al 
examined the effects of Syzygium cumini (L.) essential oil 
(ScEO) and its major component α-pinene on Leishmania 
(Leishmania) amazonensis. Anti-proliferative effect on 
Leishmania, effects on promastigote and axenic amastigote 
forms were assessed using tetrazolium salt (MTT) assay. The 
intramacrophagic amastigotes were exposed to ScEO and α-
pinene to evaluate the survival index. Results revealed that 
α-Pinene was effective against Leishmania amazonensis 
promastigote forms, having 50% inhibitory concentration 
(IC50) value of 19.7 μg/mL. α-Pinene was more active (IC50 
values of 16.1 and 15.6 μg/mL against axenic and 
intracellular amastigotes, respectively) than ScEO (IC50 
values of 43.9 and 38.1 μg/mL against axenic and 
intracellular amastigotes, respectively).(40) This report 
suggests that it may be used in prevention and treatment of 
Leishmaniasis. 
10. Antihyperlipidemic Activity: Kasiappan et al in their 
study showed oral administration of ethanolic extract of E. 
jambolana-kernel (100mg/kg body weight) had 
antihyperlipidermic activity on streptozotocin induced 
diabetic rats. (41) 
11. Antianaemic activity:  It has been reported that 
aqueous seeds extract of S. cumini possessed antianaemic 
activity. In a study it revealed that seed extract of the S. 
cumini increased total haemoglobin. (42) 
12. Antibacterial activity: Bhuiyan et al in their study 
reported that methanol and ethyl acetate extracts of the 
seeds of E. jambolana at a concentration of 200 μg/disc 
showed antibacterial activity against Bacillus creus, B. 
subtalis, B. megateriun, Steptococcus ß–haemolyticus, S. 
aureus, Shigella dysenteriae, Sh. Shiga, Sh. boydii, Sh. 
flexneriae, Sh. sonnei, E. coli, S. typhi B, S. typhi and Klebsiella 
species.(43) ) An extract of the leaves of the E. jambolana also 
showed moderate antibacterial activity against Escherichia 
coli and antibiotic activity against Micrococcus pyogenes var 
aureus. (3)  
13. Anti-fertility Activity: Rajasekaran et al has reported 
anti-fertility activity of oleanolic acid isolated from the 
flowers of E. jambolana. It decreased the fertilizing capacity 
of the male albino rats without any significantly change in 
body or reproductive organ weights. It caused significant 
reduction in conversion of spermatocytes to spermatides and 
arrest of spermatogenesis at the early stages of meiosis 
leading to decrease in sperm count without any abnormality 
to spermatogenic cells, leyding interstitial cells and sertoli 
cells. (44) 
14. CNS Protective Activity: Kumar et al. investigated the 
ethyl acetate and methanol extracts of the seeds of S. cumini 
for CNS activity on albino mice at dose levels of 200 and 400 
mg/kg. Both extracts exhibited significantly CNS protective 
activity. (45) 
15. Antinephrotoxic Activity: Adikay et al. studied the 
nephroprotector activity of an ethanol extract of fruits of S. 
cumini (250 and 500 mg/kg taken by mouth) on cisplatin-
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induced nephrotoxicity (6 mg/kg intraperitoneally) in albino 
rats. The nephroprotector activity of S. cumini was assessed 
by estimating the levels of blood urea nitrogen, serum 
creatinine, serum total proteins, urinary protein, and lipid 
peroxidation in the kidney. Cisplatin elevated the serum 
marker level, increased the protein excretion in urine, 
reduced the creatinine clearance, and increased the renal 
MDA level. Animals that received an ethanol extract of fruits 
of S. cumini significantly reversed the effects induced by 
cisplatin in a dose-dependent manner. (46)  
16. Radio protective Effect: The leaves of S. cumini were 
tested as a radioprotectant using a micronucleus assay. S. 
cumini was found to reduce the formation of micronuclei in 
lymphocytes. (47) Arun et al. also confirmed that seed extract 
of S. cumini inhibited the micronuclei formation in mouse 
bone marrow cells induced by genotoxic stress. Similar to 
previous   observations, S. cumini extract reduced the 
incidence of micronuclei, and a concentration-dependent 
inhibition of lipid peroxides was also observed in mice brain 
extract prepared after irradiation. (48) 
17. Immunomodulatory Activity: Seed extract of S. cumini 
was studied for its immunomodulatory activity. It was found 
to increase the delayed-type hypersensitivity (DTH) reaction 
and humoral antibody titres in rats in a dose-dependent 
manner. Similarly, the treatment also increased the total 
number of white blood cells, neutrophils, and lymphocytes in 
rats. (49)This study pointed out that S. cumini seed extract had 
the potential to stimulate the hematopoietic system of the 
body, which, in turn, indicated that the plant had treatment 
potential in immune-deficient conditions arising during 
radiation therapy or chemotherapy. 
18. Antioxidant Activity: Zhi-Ping et al. investigated the 
antioxidant activity of S. cumini leaf extracts using the  2,2-
diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging 
and ferric reducing antioxidant power (FRAP) assays. In this 
study the results showed that the ethyl acetate fraction had 
stronger antioxidant activity than the other ones. High-
performance liquid chromatography (HPLC) data indicated 
that S. cumini leaf extracts contained phenolic compounds, 
such as ferulic acid and catechin, responsible for their 
antioxidant activity. (50) 
Conclusion:  
Jamun (S. cumini) is one of the known herbal medicinal 
plants in Unani system of medicine (USM). Its various parts 
such as fruits, seeds (kernel), leaves and bark possesses 
medicinal values. It is commonly used as anti-diarrhoeal, 
digestive, astringent and antibacterial drug. In classical 
literature, it is indicated for Ḍu‘f al-Mi‘da (weakness of 
stomach), Ishāl-e- Damwī (haemorrhagic diarrhoea), Is’hāl-i- 
Ṣafrāwī (bilious diarrhoea) and Dhayābīṭus Ḥārr (diabetes 
mellitus). In several experimental studies, it has been 
reported that it possesses Dafi‘-i-Dhayābīṭus (antidiabetic), 
Muḥallil-i- Awrām (anti-inflammatory), Dafi‘-i-Jarāsīm 
(antibacterial) and Dafi‘-i-Ḥummā (antipyretic) actions. Its 
encouraging result reported in various preclinical studies 
suggested that it may be used as a study drug in clinical trial 
to test its efficacy as Dafi‘-i-Dhayābīṭus (antidiabetic), 
Muḥallil-i- Awrām (anti-inflammatory), Dafi‘-i-Jarāsīm 
(antibacterial) and Dafi‘-i-Ḥummā (antipyretic) potential. In 
future, clinical studies should be designed to validate and 
document the efficacy of its various parts as described in 
classical literature so that it can be used as a potential drug 
to treat and manage non-communicable diseases. Such 
studies may help in bringing USM into mainstream that is 
one of the objective of National Health Policy 2017. 
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